DRTS Alpha Tau Medical Ltd.: institutional ownership and insider trading
75 funds reported holding $111M of Alpha Tau Medical Ltd. in their latest 13F filings; in Q2 2026 funds net bought $57.0M, with 26 new positions and 6 funds selling out; over the last 12 months insiders bought $0 and sold $1.56M on the open market.
Famous investors holding DRTS
- Cathie Wood (ARK Investment Management): $3.49M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $4.72M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $170K, 0.0% of the portfolio
Largest institutional holders of DRTS
- Gem Investment Advisors, LLC — $18.0M
- HighTower Advisors, LLC — $11.0M
- BOOTHBAY FUND MANAGEMENT, LLC — $9.73M
- Aquamarine Financial (Cayman) Ltd — $9.08M
- Pier Capital, LLC — $8.70M
- UBS Group AG (UBS) — $8.08M
- SUSQUEHANNA INTERNATIONAL GROUP, LLP — $5.56M
- Apella Capital, LLC — $5.45M
- CITADEL ADVISORS LLC — $4.72M
- ARK Investment Management LLC — $3.49M
Recent DRTS insider trades
- Aug 21, 2026: Levy Raphi sold 2,871 shares ($43.1K)
- Aug 11, 2026: Levy Raphi sold 17,730 shares ($248K)
- Jul 6, 2026: Levy Raphi sold 2,270 shares ($31.8K)
- Jul 2, 2026: Levy Raphi sold 17,873 shares ($232K)
5%+ owners
- Oramed Pharmaceuticals Inc.: 20.0% (Schedule 13D, filed May 1, 2025)
- Uzi Sofer: 15.8% (Schedule 13G, filed Jul 24, 2025)